RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review

  • ID: 4308175
  • SWOT Analysis
  • 44 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • American Regent Inc
  • Apotex Inc
  • Hikma Pharmaceuticals Plc
  • Impax Laboratories Inc
  • Mylan Pharmaceuticals Inc
  • MORE
RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., is a pharmaceutical company which focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms, each with a clinical stage compound directed at breathing disorders. The company’s respiratory disease product pipeline includes compounds in various development stages for the treatment of obstructive sleep apnea (OSA), chronic and post-surgical central sleep apnea (CSA), opioid induced respiratory depression, spinal cord injury, and induced respiratory depression. Its lead product, Dronabinol is an oral capsule drug product in Phase II trials for the treatment of OSA. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc Key Recent Developments

Nov 15,2016: RespireRx Pharmaceuticals Files September 30, 2016 Quarterly Report on Form 10-Q
Aug 15,2016: RespireRx Pharmaceuticals Files June 30, 2016 Quarterly Report on Form 10-Q
May 17,2016: RespireRx Pharmaceuticals Files March 31, 2016 Quarterly Report on Form 10-Q
Apr 01,2016: RespireRx Pharmaceuticals, the University of Alberta and the University of Florida Provide Update on Collaborative Research Activities
Mar 29,2016: RespireRx Pharmaceuticals Files December 31, 2015 Annual Report on Form 10-K

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • American Regent Inc
  • Apotex Inc
  • Hikma Pharmaceuticals Plc
  • Impax Laboratories Inc
  • Mylan Pharmaceuticals Inc
  • MORE
Section 1 - About the Company
RespireRx Pharmaceuticals Inc - Key Facts
RespireRx Pharmaceuticals Inc - Key Employees
RespireRx Pharmaceuticals Inc - Key Employee Biographies
RespireRx Pharmaceuticals Inc - Major Products and Services
RespireRx Pharmaceuticals Inc - History
RespireRx Pharmaceuticals Inc - Company Statement
RespireRx Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
RespireRx Pharmaceuticals Inc - Business Description
RespireRx Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
RespireRx Pharmaceuticals Inc - Strengths
RespireRx Pharmaceuticals Inc - Weaknesses
RespireRx Pharmaceuticals Inc - Opportunities
RespireRx Pharmaceuticals Inc - Threats
RespireRx Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
RespireRx Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Nov 15, 2016: RespireRx Pharmaceuticals Files September 30, 2016 Quarterly Report on Form 10-Q
Aug 15, 2016: RespireRx Pharmaceuticals Files June 30, 2016 Quarterly Report on Form 10-Q
May 17, 2016: RespireRx Pharmaceuticals Files March 31, 2016 Quarterly Report on Form 10-Q
Apr 01, 2016: RespireRx Pharmaceuticals, the University of Alberta and the University of Florida Provide Update on Collaborative Research Activities
Mar 29, 2016: RespireRx Pharmaceuticals Files December 31, 2015 Annual Report on Form 10-K

Section 6 - Appendix
Methodology
Ratio Definitions
About the Publisher
Contact Us
Disclaimer

List of Tables:
RespireRx Pharmaceuticals Inc, Key Facts
RespireRx Pharmaceuticals Inc, Key Employees
RespireRx Pharmaceuticals Inc, Key Employee Biographies
RespireRx Pharmaceuticals Inc, Major Products and Services
RespireRx Pharmaceuticals Inc, History
RespireRx Pharmaceuticals Inc, Subsidiaries
RespireRx Pharmaceuticals Inc, Key Competitors
RespireRx Pharmaceuticals Inc, Ratios based on current share price
RespireRx Pharmaceuticals Inc, Annual Ratios
RespireRx Pharmaceuticals Inc, Annual Ratios (Cont...1)
RespireRx Pharmaceuticals Inc, Interim Ratios
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
RespireRx Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures:
RespireRx Pharmaceuticals Inc, Performance Chart (2012 - 2016)
RespireRx Pharmaceuticals Inc, Ratio Charts
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceuticals USA Inc
  • Mylan Pharmaceuticals Inc
  • Impax Laboratories Inc
  • Hikma Pharmaceuticals Plc
  • Breckenridge Pharmaceutical Inc
  • Apotex Inc
  • American Regent Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll